Bristol-Myers Squibb Co (BMY)
44.93
+0.19
(+0.42%)
USD |
NYSE |
May 10, 16:00
44.54
-0.39
(-0.87%)
After-Hours: 18:11
Bristol-Myers Squibb Cash and Short Term Investments (Quarterly): 9.67B for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.67B |
| December 31, 2023 | 12.28B |
| September 30, 2023 | 7.685B |
| June 30, 2023 | 8.73B |
| March 31, 2023 | 9.269B |
| December 31, 2022 | 9.253B |
| September 30, 2022 | 9.027B |
| June 30, 2022 | 13.27B |
| March 31, 2022 | 15.20B |
| December 31, 2021 | 17.22B |
| September 30, 2021 | 15.82B |
| June 30, 2021 | 14.02B |
| March 31, 2021 | 13.14B |
| December 31, 2020 | 16.45B |
| September 30, 2020 | 21.28B |
| June 30, 2020 | 21.79B |
| March 31, 2020 | 18.32B |
| December 31, 2019 | 15.39B |
| September 30, 2019 | 32.54B |
| June 30, 2019 | 29.36B |
| March 31, 2019 | 8.764B |
| December 31, 2018 | 8.759B |
| September 30, 2018 | 6.83B |
| June 30, 2018 | 6.075B |
| March 31, 2018 | 6.77B |
| Date | Value |
|---|---|
| December 31, 2017 | 6.812B |
| September 30, 2017 | 7.122B |
| June 30, 2017 | 6.505B |
| March 31, 2017 | 6.109B |
| December 31, 2016 | 6.35B |
| September 30, 2016 | 5.56B |
| June 30, 2016 | 4.651B |
| March 31, 2016 | 4.307B |
| December 31, 2015 | 4.27B |
| September 30, 2015 | 5.413B |
| June 30, 2015 | 5.476B |
| March 31, 2015 | 7.607B |
| December 31, 2014 | 7.435B |
| September 30, 2014 | 7.221B |
| June 30, 2014 | 7.175B |
| March 31, 2014 | 7.059B |
| December 31, 2013 | 4.525B |
| September 30, 2013 | 2.722B |
| June 30, 2013 | 2.799B |
| March 31, 2013 | 2.533B |
| December 31, 2012 | 2.829B |
| September 30, 2012 | 2.93B |
| June 30, 2012 | 5.037B |
| March 31, 2012 | 5.029B |
| December 31, 2011 | 8.733B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
7.685B
Minimum
Sep 2023
32.54B
Maximum
Sep 2019
15.49B
Average
14.61B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Amgen Inc | 9.708B |
| Gilead Sciences Inc | 4.718B |
| Johnson & Johnson | 26.22B |
| Karuna Therapeutics Inc (DELISTED) | 1.263B |
| 2seventy bio Inc | 216.99M |